Extrasystolen — sind sie blande und mit einer kurativen Ablation aus der Welt zu schaffen oder erstes Symptom einer ernstzunehmenden kardiologischen Grunderkrankung? Welche Anhaltspunkte haben Sie, um die richtige Entscheidung für Ihre Patienten treffen zu können? Die folgenden beiden Kasuistiken verdeutlichen dies exemplarisch.
Literatur
Ito S, Tada H, Naito S, Kurosaki K, Ueda M, Hoshizaki H, Miyamori I, Oshima S, Taniguchi K, Nogami A. Development and validation of an ECG algorithm for identifying the optimal ablation site for idiopathic ventriculuar outflow tract tachycardia. J Cardiovasc Electrophysiol 2003;14:1280–1286
Ouyang F, Fotuhi P, Ho SY, Hebe J, Volkmer M, Goya M, Burns M, Antz M, Ernst S, Cappato R, Kuck KH. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol 2002;39:500–508
Mountantonakis, SE, Frankel DS, Gerstenfeld EP, Dixit S, Lin D, Hutchinson M D, Riley M et al. Reversal of outflow tract ventricular premature depolarization-induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome. Heart rhythm 2011;8(10):1608–1614 doi:10.1016/j.hrthm.2011.04.026
Liu N, Colombi B, Raytcheva-Buono EV, Bloise R, & Priori SG. Catecholaminergic polymorphic ventricular tachycardia. Herz 2007;32(3):212–217 doi:10.1007/s00059-007-2975-2
Jung W, Andresen D, Block M, Böcker D, Hohnloser SH, Kuck K-H, Sperzel J. Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 2006;95:696–708
Maron BJ, McKenna WJ, Danielson GK et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003;24:1965–1991
Maron BJ, Shen WK, Link MS et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365–373
Kuck K-H, Ernst S, Dorwarth U, Hoffmann E, Pitschner H, Tebbenjohanns J, Kottkamp H. Leitlinien zur Katheterablation. Clin Res Cardiol 2007;96:833–849
Kanei Y, Friedman M, Ogawa N, Hanon S, Lam P, Schweitzer P. Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction. Ann Noninvasive Electrocardiol. 2008;13(1):81–5
Niwano S, Wakisaka Y, Niwano H, Fukaya H, Kurokawa S, Kiryu M, Hatakeyama Y, Izumi T. Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function. Heart 2009;95(15):1230–7 epub 2009 May 7
Takemoto M, Yoshimura H, Ohba Y, Matsumoto Y, Yamamoto U, Mohri M, Yamamoto H, Origuchi H. Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease. J Am Coll Cardiol 2005; 45(8):1259–65
Wijnmaalen AP, Delgado V, Schalij MJ, van Huls van Taxis CF, Holman ER, Bax JJ, Zeppenfeld K. Beneficial effects of catheter ablation on left ventricular and right ventricular function in patients with frequent premature ventricular contractions and preserved ejection fraction. Heart 2010;96(16):1275–80
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003;24(21):1965–91
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
von Bodman, G., Brömsen, J., Kopf, C. et al. Harmlos oder gefährlich?. MMW - Fortschritte der Medizin 155, 60–63 (2013). https://doi.org/10.1007/s15006-013-0437-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-013-0437-8